← Leaderboards
Ursula D Ramirez
Vironika, Llc
$900,001
Attributed
$900,001
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2016–19$500K$375K$250K$125K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$900,001 · 2
By mechanism
R43$900,001 · 2
Top collaborators
No co-investigators on record.
Most similar at Vironika, Llc
Same institution · by research overlap
- Troy E Messick$3,405,267
- Takahiro Yano$1,449,278
- Mark E McDonnell$4,736,700
- Pieter Van Den Heuvel$505,000
Others in their field
Top investigators on “S Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
S LymphomaMonitorAnimal ModelLibrariesDrug KineticsMedicalFluorescence PolarizationFoxesImmune System DiseasesLeadBiotechnologyBaseMalignant NeoplasmsEpstein-Barr Virus InfectionsHodgkin DiseaseDetectionCell GrowthBiochemicalCellsHuman Herpesvirus 4ChronicInhibitor/AntagonistCollaborationsLymphomagenesis
Grant awards (3)
Small Molecule Targeting of Viral Non-Coding RNA EBER1 to Detect and Treat Latent EBV$300,000
R43 · FY2019 · AI · contact PI
Small Molecule Targeting of Viral Non-Coding RNA EBER1 to Detect and Treat Latent EBV$300,000
R43 · FY2018 · AI · contact PI
Development of a Small Molecule Inhibitor for EBV Lytic Reactivation$300,001
R43 · FY2016 · AI · contact PI